Skip to main content

Table 2 Crude risk of increasing serum concentrations of uric acid

From: Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study

   Odds ratio for outcome
  Serum uric acid concentration, μmol/L [mg/dL] Agatston score >0 vs. Agatston score = 0   Agatston score >10 vs. Agatston score <10  
Men (n = 1,211)      
   Quartile 1 155-291 [2.6-4.9] 1   1  
   Quartile 2 297-333 [5.0-5.6] 1.17 (0.71-1.95) 1.21 (0.65-2.23)
   Quartile 3 339-393 [5.7-6.6] 1.56 (0.96-2.54) 1.62 (0.91-2.91)
   Quartile 4 399-690 [6.7-11.6] 2.07 (1.30-3.31) 2.08 (1.19-3.67)
Women (n = 1,287)      
   Quartile 1 77-196 [1.3-3.3] 1   1  
   Quartile 2 196-226 [3.3-3.8] 1.50 (0.66-3.38) 1.49 (0.52-4.22)
   Quartile 3 232-274 [3.9-4.6] 1.44 (0.65-3.23) 1.5 (0.54-4.17)
   Quartile 4 280-636 [4.7-10.7] 2.47 (1.17-5.22) 2.93 (1.15-7.49)
Overall (n = 2,498)      
   Quartile 1 77-291 [1.3-4.9] 1   1  
   Quartile 2 196-333 [3.3-5.6] 1.25 (0.81-1.91) 1.27 (0.75-2.15)
   Quartile 3 232-393 [3.9-6.6] 1.47 (0.98-2.22) 1.54 (0.93-2.54)
   Quartile 4 280-690 [4.7-11.6] 2.11 (1.42-3.12) 2.24 (1.39-3.60)